From ‘liquid biopsies’ to precision medicine, these five developments will change cancer care in the next decade. Learn more.

Reply
Highlighted
Valued Social Butterfly
0
Kudos
377
Views
0
Replies

IMPORTANT: Blood Pressure Med RECALL by FDA

377 Views
Message 1 of 1

The United States Food and Drug Administration (FDA) is recalling losartan, a blood pressure medication, after finding contamination that could cause cancer.

 

The voluntary recall of losartan potassium hydrochlorothiazide by pharmaceutical company Sandoz Inc., is for 100 milligram/25 milligram tablets with the lot number JB8912. The affected product was distributed nationwide on or after October 8, 2018. In total, the recall encompasses less than 1% of the national losartan drug products. The FDA reports that so far, Sandoz has not received any reports of adverse events related to the drug.

 

. . . . . If this sounds familiar, it’s because the FDA recently recalled blood pressure drug irbesartan for the exact same reason. That product callback followed on another NDEA-related drug recall, for another blood pressure medication, valsartan, back in July.

 

Read More at:

http://fortune.com/2018/11/12/fda-drug-recall-blood-pressure-losartan/

* * * * It's Always Something . . . Roseanne Roseannadanna
Report Inappropriate Content
0
Kudos
377
Views
0
Replies
cancel
Showing results for 
Search instead for 
Did you mean: 
Users
Announcements

Are you new to the online community? Say Hi and tell us a bit about yourself, your interests, and how we can help make this community a great experience for you!


close-up group of seniors smiling at camera